active pharmaceutical ingredients, biocon, cdsco, cipla, clinical trials india, coronavirus, drug price control order, drugs and cosmetics rules, glp-1 weight loss drugs, good manufacturing practices, health, india drug regulator, india pharma industry, journalist, journalists, lupin, minimum import price, national pharmaceutical pricing authority, news, pharma, pharmaceutical supply chain, pharmexcil, schedule m compliance, spurious drugs, sun pharma, ihh healthcare, semaglutide, pharmaceutical industry, daiichi sankyo, fortis healthcare, obesity treatment, glp-1 drugs, fssai, pharmaceutical industry in india